Published 19:17 IST, August 3rd 2020
WHO chief says 'no silver bullet' yet for COVID-19 as vaccine trials continue
The World Health Organisation chief warned on August 3 that there might never be a “silver bullet” for the novel coronavirus despite several vaccine trials.
Advertisement
World Health Organisation (WHO) chief warned on August 3 that re might never be a “silver bullet” for vel coronavirus despite several vaccine trials. dressing a virtual press briefing, WHO Director-General Tedros ham Ghebreyesus said that Emergency Committee on COVID-19 met and reviewed ongoing pandemic.
“A number of vaccines are w in phase three clinical trials and we all hope to have a number of effective vaccines that can help prevent people from infection. However, re’s silver bullet at moment and re might never be,” said top WHO official.
Dr Ghebreyesus called meeting a “sobering moment” as committee h vised that outbreak constituted a Public Health Emergency of International Concern. On January 30, re were fewer than 100 cases and reported deaths outside China and in three months, three million COVID-19 cases and over 200,000 h been reported to WHO.
Advertisement
“Since n, number of cases has increased more than fivefold to 17.5 million, and number of deaths has more than tripled, to 680,00,” ded Dr Ghebreyesus.
Advertisement
WHO chief highlighted that world has witnessed social, ecomic, and political damd caused by coronavirus, apart from health impact. Emergency Committee has put forward a number of recommendations for countries to bring virus under control.
Coronavirus origins investigation
Dr Ghebreyesus also provided updates on investigation into origin of coronavirus, which is believed to be originated from a wet market in Wuhan. He said that WHO vance team that travelled to China has w concluded ir mission to lay groundwork for furr joint efforts to identify virus origins. WHO and Chinese experts have drafted ‘Terms of Reference’ for studies and programme of work for an international team’
Advertisement
“Epidemiological studies will begin in Wuhan to identify potential source of infection of early cases. Evidence and hyposes generated through this work will lay ground for furr, longer-term studies,” he ded.
Advertisement
19:17 IST, August 3rd 2020